Unlock regulatory insights with Watson. Learn More

Declare That Atropine Sulfate Injection, USP 1.0 mg/mL, 1 mL fill in a 1 mL Glass Ampule is Suitable for Submission as an Abbreviated New Drug Application (ANDA) - CLOSED

KeyWord(s) cder, ANDA, atropine sulfate, suitability, injection, glass ampule, 021146, nda, ansyr, plastic syringe, hospira, RLD, 2012-7852, open
Short title Declare That Atropine Sulfate Injection, USP, in a Glass Ampule is Suitable for Submission as an ANDA
Docket Item Code P
Center CDER
VIEW ALL (1)Primary Documents